title: [Preparation of patients with haemostatic disorder for invasive medical interventions].
abstract: The current trend in medicine is to sustain the possibility for necessary procedures to be performed in patients who suffer from haemostatic disorders which complicate eventual surgery. Among such disorders are congenital blood coagulation disorders, haemostatic disorders concomitant with other diseases and also therapies which affect haemostasis either on purpose or as part of adverse effects. Among coagulation disorders are congenital haemorrhagic or thrombotic conditions, acquired blood coagulation disorders--combined in the vast majority of cases-- and associated with pregnancy, severe internal diseases and surgery related diseases, severe injuries, wounds, burns, malignancies, systemic connective tissue diseases, inflammatory bowel disease, and a number of other diseases. A separate issue is that ofanticoagulation therapy--both antiplatelet, used in the treatment or prevention of venous thrombosis, and anticoagulation, predominantly used to manage venous thromboembolism. Also considered should be any therapy which may have a negative impact on coagulation due to its adverse effects.
authors.affiliation: Univerzitní centrum pro trombózu a hemostázu MU Brno. m.penka@fnbrno.cz
authors.forename: M
authors.initials: M
authors.lastname: Penka
authors.forename: A
authors.initials: A
authors.lastname: Buliková
authors.forename: P
authors.initials: P
authors.lastname: Smejkal
authors.forename: J
authors.initials: J
authors.lastname: Kissová
authors.forename: M
authors.initials: M
authors.lastname: Matýsková
authors.forename: J
authors.initials: J
authors.lastname: Gumulec
authors.forename: S
authors.initials: S
authors.lastname: Králová
authors.forename: M
authors.initials: M
authors.lastname: Slechtová
authors.forename: G
authors.initials: G
authors.lastname: Chlupová
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000628:therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D011300:Preoperative Care
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents